A Multicenter study on the proper use and safety of ponatinib based on PK/PD/PGx
Latest Information Update: 18 Jun 2019
At a glance
- Drugs Ponatinib (Primary)
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
Most Recent Events
- 13 Jun 2019 Status changed from not yet recruiting to recruiting.
- 24 Dec 2018 New trial record